Avery Biomedical Devices, Inc. Names Matt Ison National Sales Director
(firmenpresse) - COMMACK, NY -- (Marketwire) -- 01/10/12 -- Avery Biomedical Devices, manufacturer of the Mark IV Breathing Pacemaker System, has named Matt Ison as its National Sales Director.
Mr. Ison will be available for consultation, in-service and promotion of the only diaphragm pacing system with full Premarket Approval from the FDA. Avery Biomedical Devices currently sells worldwide and wants to increase awareness of the positive benefits the Breathing Pacemaker System has for patients with high spinal cord injuries, congenital or acquired central hypoventilation syndrome or diaphragm paralysis of various etiologies.
"The addition of Matt will further our efforts to reach those who can benefit from the Avery System," noted Linda Towler, CEO of Avery Biomedical Devices. "Matt's comprehensive understanding of the medical device market along with his consultation and training abilities will greatly benefit Avery Biomedical Devices and our patients."
About ABD
Avery Biomedical Devices, Inc. (ABD) is a privately-held company located on Long Island, New York. It manufactures the breathing pacemaker: an implanted phrenic nerve stimulator which is used to free many quadriplegic and central hypoventilation patients from mechanical ventilation.
ABD is ISO-9001 certified, ISO-13485 compliant, and an FDA registered manufacturer of Class III medical devices.
CONTACT
Kenneth R. Aron
Vice President for Sales & Marketing
631-864-1600, x205
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.01.2012 - 17:06 Uhr
Sprache: Deutsch
News-ID 102839
Anzahl Zeichen: 10708
contact information:
Town:
COMMACK, NY
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 244 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Avery Biomedical Devices, Inc. Names Matt Ison National Sales Director"
steht unter der journalistisch-redaktionellen Verantwortung von
Avery Biomedical Devices, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
